Delayed neurotoxicity of intraventricular interleukin-2: A case report

Journal of Neuro-Oncology

Volumn 15, Issue 3, 1993, Pages 265-267

  Meyers, Christina A ^a   Yung, W K Alfred ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

interleukin 2; neuropsychological testing; neurotoxicity

Indexed keywords

INTERLEUKIN 2;

ADULT; ARTICLE; BRAIN INJURY; BRAIN TOXICITY; DEMENTIA; DETERIORATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MENINX DISORDER; WORK CAPACITY;

ADULT; BRAIN DISEASES; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-2; TIME FACTORS;

EID: 0027278981     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/BF01050073     Document Type: Article

References (7)

1. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
2. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: Phase I trial
3. Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier
4. Transient focal neurologic deficits complicating interleukin-2 therapy
5. Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions
6. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects
7. Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats